Dr. Barb Kinnaird

Proven CEO and industry expert Dr. Barb Kinnaird helps companies bridge the gap between innovation and profitability. With over 20 years in leadership roles primarily in the field of point of care diagnostics, Dr. Kinnaird is passionate about guiding leaders through transitions by focusing on organizational mindsets and their products to elevate and grow company value. Dr. Kinnaird has served as Chief Executive Officer of Response Biomedical Corporation since 2015. Through her leadership, Response Biomedical has transformed and expanded from a niche market into a global acute care diagnostics leader, expanding product availability worldwide to improve patient outcomes and support decentralization of diagnostic testing. A patent-holder and author of numerous academic publications, Dr. Kinnaird is an active leader in the global medical diagnostic community and a sought-after mentor to fellow CEOs. Barb holds a Level 2 certification from the Innovation Governance Program (iGP), a cutting-edge Board Governance program. Since 2019, she has served as a Director on the Board of Acetech, a Canadian non-profit organization designed by CEOs to help CEOs grow and scale tech businesses and stimulate the economy through job creation and global expansion. Dr. Kinnaird holds a Ph.D. in Microbiology and Immunology from the University of British Columbia. She conducted her post-doctoral research at the Michael Smith Laboratories in genomics and gene expression profiling, in collaboration with the B.C. Genome Sciences Centre while acting as a consultant for the Proteomics division of Incyte Genomics Inc. She continues to share her expertise in life sciences as an Advisor to Genome BC and Global Affairs Canada.